Publication:
Trajectories of body mass index before the diagnosis of cardiovascular disease: a latent class trajectory analysis

Thumbnail Image

Open/View Files

Date

2016

Journal Title

Journal ISSN

Volume Title

Publisher

Springer Netherlands
The Harvard community has made this article openly available. Please share how this access benefits you.

Research Projects

Organizational Units

Journal Issue

Citation

Dhana, Klodian, Joost van Rosmalen, Dorte Vistisen, M. Arfan Ikram, Albert Hofman, Oscar H. Franco, and Maryam Kavousi. 2016. “Trajectories of body mass index before the diagnosis of cardiovascular disease: a latent class trajectory analysis.” European Journal of Epidemiology 31 (1): 583-592. doi:10.1007/s10654-016-0131-0. http://dx.doi.org/10.1007/s10654-016-0131-0.

Research Data

Abstract

Patients with cardiovascular disease (CVD) are a heterogeneous group regarding their body mass index (BMI) levels at the time of diagnosis. To address the heterogeneity of CVD, we examined the trajectories of change in body mass index (BMI) and in other cardio-metabolic risk factors before CVD diagnosis. The study included 6126 participants from the prospective population-based Rotterdam Study, followed over 22 years with clinical examinations every 4 years. Latent class trajectory analysis and mixed-effect models were used to develop trajectories of BMI and other cardio-metabolic risk factors respectively. During follow-up, 1748 participants developed CVD, among whom we identified 3 distinct BMI trajectories. The majority of participants (n = 1534, 87.8 %) had steady BMI levels during follow-up, comprising the “stable weight” group. This group showed decrease in mean high-density lipoprotein (HDL) cholesterol over time. The second group, the “progressive weight gain” group (n = 112, 6.4 %), showed a progressive increase in BMI levels. In this group, mean waist circumference increased, mean HDL cholesterol decreased and mean fasting glucose levels were fluctuating over follow-up. In the third group, the “progressive weight loss” group (n = 102, 5.8 %), BMI levels decreased during follow-up. This group showed a decrease in mean waist circumference and in fasting glucose. In conclusion, the majority of individuals who developed CVD had a stable weight during follow-up, suggesting that BMI alone is not a good indicator for identifying middle-aged and elderly individuals at high risk of CVD. Waist circumference, HDL cholesterol, and glucose trajectories differed between the identified BMI subgroups, further highlighting that CVD is a heterogeneous disease with different pathophysiological pathways. Electronic supplementary material The online version of this article (doi:10.1007/s10654-016-0131-0) contains supplementary material, which is available to authorized users.

Description

Keywords

Obesity/physiopathology, Cardiovascular disease, Body mass index, Blood pressure, Lipids, Glucose

Terms of Use

This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service

Endorsement

Review

Supplemented By

Referenced By

Related Stories